BridgeBio Pharma, Inc.
Pharmaceutical Preparations · Palo Alto, CA, United States
- PrincipalsMaricel ApuliChief Accounting OfficerNeil KumarChief Executive OfficerThomas TrimarchiPresident and CFOand 6 more
- CompanyBridgeBio Pharma, Inc.Palo Alto, CA, United States
- Phone line+1 (650) 391-9740General business
BridgeBio Pharma, Inc. is an SEC-registered Nasdaq-listed company (ticker BBIO) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 9
Chair & board
Andrea EllisDirector (Board)
Andrew LoDirector (Board)
Frank McCormickDirector (Board)
Hannah ValantineDirector (Board)
Finance
Maricel ApuliChief Accounting Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Thomas Trimarchi — President and CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Andrea Ellis — Director (Board)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Maricel Apuli — Chief Accounting Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Neil Kumar — Chief Executive Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
BeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityXenon Pharmaceuticals Inc.Pharmaceutical Preparations · Burnaby1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityAmarin Corp PLC\UKPharmaceutical Preparations · Dublin 21 shared capability